A Study of SGN-STNV in Advanced Solid Tumors
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Carcinoma, Non-Small Cell Lung|HER2 Negative Breast Neoplasms|Ovarian Neoplasms|Uterine Cervical Neoplasms|Endometrial Neoplasms|Esophageal Neoplasms|Gastroesophageal Junction Carcinoma|Stomach Neoplasms|Colorectal Neoplasms|Exocrine Pancreatic Adenocarcinoma|Appendiceal Adenocarcinoma|Pseudomyxoma Peritonei
Interventions: DRUG: SGN-STNV
Sponsor: Seagen Inc.